New York Oncology Hematology, P.C. Dept. of New York Oncology. PC

Troy, New York 12180

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma

Studies at this site

• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation — Completed
• Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer — Stopped early
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed